Who is sponsoring NCT06305156?

NCT06305156 is sponsored by Hatem Alkadhi.

What drugs are being tested in NCT06305156?

Interventions in NCT06305156: Bone Mineral Density quantification.

What condition does NCT06305156 study?

NCT06305156 studies Osteoporosis, Osteopenia, Bone Loss.

Is NCT06305156 still recruiting?

NCT06305156 is currently completed. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT06305156

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protocol Optimization in CT for the Quantification of BMD

Completed NA Last updated 13 January 2026

What this trial tests

NA trial testing Bone Mineral Density quantification in Osteoporosis, Osteopenia in 167 participants. Completed in 19 December 2025.

Timeline

13 March 2024

Primary endpoint
19 December 2025

19 December 2025

Quick facts

Lead sponsor	Hatem Alkadhi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	167
Start date	13 March 2024
Primary completion	19 December 2025
Estimated completion	19 December 2025
Sites	1 location across Switzerland

Drugs / interventions tested

Bone Mineral Density quantification

Conditions studied

Osteoporosis, Osteopenia — all drugs for Osteoporosis, Osteopenia →
Bone Loss — all drugs for Bone Loss →

Sponsor

Hatem Alkadhi

Who can join

18 and older, any sex, with Osteoporosis, Osteopenia or Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bone mineral density is an important measurement to detect osteoporosis. The goal of this clinical trial is to compare bone mineral density measurements in CT examinations and DXA scans. The main question it aims to answer is: * How good is the measurement of bone mineral density in the new photon-counting CT in comparison to DXA * How can we optimize the CT scan for bone mineral density Participants will undergo: * Clinically indicated CT scan on day of inclusion * Study related DXA scan on a separate appointment

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoporosis, Osteopenia

Currently open trials in the same condition.

NCT05712252 — Fall, Fracture and Frailty · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06305156 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hatem Alkadhi
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06305156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing